You can buy or sell Arvinas and other stocks, options, ETFs, and crypto commission-free!
Arvinas, Inc. Common Stock, also called Arvinas, is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapies to degrade disease-causing proteins. Read More Its lead products include ARV-110 and ARV-471. The company was founded in February 2013 and is headquartered in New Haven, CT.
New Haven, Connecticut
52 Week High
52 Week Low
Expected Nov 12, Pre-Market